Posted by Michael Wonder on 14 Sep 2020
U.S. hospitals turn down remdesivir, limit use to sickest COVID-19 patients
12 September 2020 - U.S. hospitals have turned down about a third of their allocated supplies of the COVID-19 drug remdesivir since July as need for the costly antiviral wanes, the Department of Health and Human Services confirmed on Friday.
Some hospitals said they are still buying the Gilead Sciences medicine to build inventory in case the pandemic accelerates over the winter.
But they said current supplies are adequate, in part because they are limiting use to severely ill patients.
